101 related articles for article (PubMed ID: 2968085)
1. The T cell response to the malaria circumsporozoite protein: an immunological approach to vaccine development.
Good MF; Berzofsky JA; Miller LH
Annu Rev Immunol; 1988; 6():663-88. PubMed ID: 2968085
[No Abstract] [Full Text] [Related]
2. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
Good MF; Branigan J; Smith G; Houghten RA
Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice.
Togna AR; Del Giudice G; Verdini AS; Bonelli F; Pessi A; Engers HD; Corradin G
J Immunol; 1986 Nov; 137(9):2956-60. PubMed ID: 2428881
[TBL] [Abstract][Full Text] [Related]
4. Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.
Good MF; Maloy WL; Lunde MN; Margalit H; Cornette JL; Smith GL; Moss B; Miller LH; Berzofsky JA
Science; 1987 Feb; 235(4792):1059-62. PubMed ID: 2434994
[TBL] [Abstract][Full Text] [Related]
5. Cloned antigens from Plasmodium falciparum as malaria vaccine candidates.
Pink JR; Caspers P; Etlinger H; Guttinger M; Matile H; Reber R; Schönfeld HJ; Sinigaglia F; Stüber D; Stürchler D
Behring Inst Mitt; 1991 Feb; (88):142-6. PubMed ID: 2049031
[TBL] [Abstract][Full Text] [Related]
6. Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.
Troye-Blomberg M; Olerup O; Perlmann H; Larsson A; Elghazali G; Fogdell A; Jepsen A; Lepers JP; Pandey JP; Grunewald J
Behring Inst Mitt; 1994 Dec; (95):97-105. PubMed ID: 7755513
[TBL] [Abstract][Full Text] [Related]
7. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
[TBL] [Abstract][Full Text] [Related]
8. The main obstacle to a malaria vaccine: the malaria parasite.
Miller LH; Good MF
Vaccine; 1988 Apr; 6(2):104-6. PubMed ID: 3291447
[TBL] [Abstract][Full Text] [Related]
9. Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite protein.
de la Cruz VF; Maloy WL; Miller LH; Lal AA; Good MF; McCutchan TF
J Immunol; 1988 Oct; 141(7):2456-60. PubMed ID: 2459211
[TBL] [Abstract][Full Text] [Related]
10. Use of prior vaccinations for the development of new vaccines.
Etlinger HM; Gillessen D; Lahm HW; Matile H; Schönfeld HJ; Trzeciak A
Science; 1990 Jul; 249(4967):423-5. PubMed ID: 1696030
[TBL] [Abstract][Full Text] [Related]
11. Peptide analysis of the T cell response to the malaria circumsporozoite (CS) protein.
Good MF; Zevering Y
Immunol Lett; 1990 Aug; 25(1-3):49-52. PubMed ID: 1980909
[TBL] [Abstract][Full Text] [Related]
12. Lack of Ir gene control in the immune response to malaria. I. A thymus-independent antibody response to the repetitive surface protein of sporozoites.
Schofield L; Uadia P
J Immunol; 1990 Apr; 144(7):2781-8. PubMed ID: 2138652
[TBL] [Abstract][Full Text] [Related]
13. [Malaria vaccine research].
Sellioğlu B
Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
[TBL] [Abstract][Full Text] [Related]
14. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
Good MF; Kumar S; Miller LH
Immunol Today; 1988 Nov; 9(11):351-5. PubMed ID: 3076406
[No Abstract] [Full Text] [Related]
15. Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity.
Playfair JH; De Souza JB; Freeman RR; Holder AA
Clin Exp Immunol; 1985 Oct; 62(1):19-23. PubMed ID: 2933196
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
17. Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.
Quakyi IA; Otoo LN; Pombo D; Sugars LY; Menon A; De Groot AS; Johnson A; Alling D; Miller LH; Good MF
Am J Trop Med Hyg; 1989 Aug; 41(2):125-34. PubMed ID: 2672834
[TBL] [Abstract][Full Text] [Related]
18. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.
Sinigaglia F; Guttinger M; Kilgus J; Doran DM; Matile H; Etlinger H; Trzeciak A; Gillessen D; Pink JR
Nature; 1988 Dec 22-29; 336(6201):778-80. PubMed ID: 2462673
[TBL] [Abstract][Full Text] [Related]
19. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria.
Hoffman SL; Oster CN; Mason C; Beier JC; Sherwood JA; Ballou WR; Mugambi M; Chulay JD
J Immunol; 1989 Feb; 142(4):1299-303. PubMed ID: 2464643
[TBL] [Abstract][Full Text] [Related]
20. The development of molecular vaccines against malaria sporozoites.
Ballou WR; Young JF; Cryz SJ; Sadoff JC
Adv Exp Med Biol; 1989; 251():295-313. PubMed ID: 2692428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
